Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.71
-0.26 (-2.90%)
At close: Jul 20, 2026, 4:00 PM EDT
8.88
+0.17 (1.95%)
After-hours: Jul 20, 2026, 7:40 PM EDT
Ocular Therapeutix Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Ocular Therapeutix stock has a consensus rating of "Strong Buy" and an average price target of $27.09. The average 1-year stock price forecast is 211.02% higher than the current stock price, while the lowest is $18 (+106.66%) and the highest is $34 (+290.36%).
Price Target: $27.09 (+211.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 7 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Maintains $21 → $23 | Buy | Maintains | $21 → $23 | +164.06% | Jun 25, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $27 | Buy | Reiterates | $27 | +209.99% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $21 → $25 | Buy | Reiterates | $21 → $25 | +187.03% | Jun 22, 2026 |
| Needham | Needham | Buy Maintains $18 | Buy | Maintains | $18 | +106.66% | Jun 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $31 | Buy | Maintains | $31 | +255.91% | Jun 18, 2026 |
Financial Forecast
Revenue This Year
51.91M
from 51.95M
Decreased by -0.08%
Revenue Next Year
120.35M
from 51.91M
Increased by 131.85%
EPS This Year
-1.55
from -1.42
EPS Next Year
-1.54
from -1.55
EPS and Forward PE are based on non-GAAP adjusted numbers.